BioVie, Inc. (BIVI)
1.56
+0.10
(+6.85%)
USD |
NASDAQ |
Apr 17, 16:00
1.59
+0.03
(+1.92%)
After-Hours: 20:00
BioVie Research and Development Expense (Quarterly) : 4.270M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Lantern Pharma, Inc. | 2.745M |
| ACADIA Pharmaceuticals, Inc. | 84.76M |
| Alnylam Pharmaceuticals, Inc. | 372.22M |
| Savara, Inc. | 20.90M |
| BioMarin Pharmaceutical, Inc. | 192.41M |